MedTrace Logo

CardioSideral Heart Surgery: Randomized Study on Sucrosomial Iron Supplementation Before Heart Surgery

NCT03560687 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1023

Last updated 2020-07-13

No results posted yet for this study

Summary

This randomized, single blind (Outcomes Assessor), non-profit study is aimed at verifying whether routine preoperative supplementation with Sucrosomial® Iron in patients scheduled for cardiac surgery may increase baseline haemoglobin, constrain the haemoglobin decrease between postoperative day 2 and 3 (haemoglobin drift), and reduce the postoperative transfusion requirements, in order to identify a new strategy for pre-hospitalization optimization and post-operative recovery.

Conditions

Interventions

DRUG

Sucrosomial Iron

CardioSideral 2 caps per day

Sponsors & Collaborators

  • Cardiochirurgia E.H.

    lead OTHER

Principal Investigators

  • Luca Weltert · European Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-15
Primary Completion
2020-05-01
Completion
2020-07-09

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03560687 on ClinicalTrials.gov